Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative...
Bicycle Therapeutics and Genentech to Develop and Commercialize Bicycle based Immuno oncology Therapies
Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based...
Biocons Insulin Manufacturing Facility in Malaysia Completes U.S. FDA Inspection
This is to inform you that the U.S. FDA conducted a pre-approval inspection (PAI) of...
RedHill Biopharma Acquires Rights to Movantik from AstraZeneca
RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on the commercialization and development...
ICON Acquires European CRO MedPass International
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical,...
DuPont Nutrition & Biosciences Enters into Collaboration with Microbiome Specialist MRM Health
DuPont Nutrition & Biosciences announced a collaboration with the MRM Health NV, a biopharmaceutical company,...
Key Themes and Technologies Highlighted at Pharmapack Europe 2020
Improving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing...
Almac Group launches enhanced Label Approval Solution (LAS)
Almac Clinical Services, a member of the global contract pharmaceutical development and manufacturing organisation, the...
Bayer, Nuvisan to create drug discovery research unit in Berlin
NUVISAN has agreed with Bayer to integratelarge partsof Bayer’s Berlin-based small molecule research unit and...
PCI Pharma Services Announces the Acquisition of Bellwyck Pharma Services
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, announced...
